The fate of Borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages. Destruction, survival, recovery
Abstract
Abstract The macrophage is a known reservoir for a number of infectious agents, and is therefore a likely candidate site for persistence of Borrelia burgdorferi, the Lyme spirochete. We report that unopsonized B. burgdorferi enter macrophages rapidly, resulting mainly in degradation but occasionally in apparent intracellular persistence. We studied uptake of spirochetes by macrophages by simultaneously labeling infected cells with antibodies to B. burgdorferi and with sequential components of the endocytic pathway, and we examined optical sections (0.5-1.0 micron in thickness) of these cells by confocal fluorescence microscopy at multiple time points after infection. We found that only 5 min of incubation at 37 degrees C were required for nearly 100% of B. burgdorferi to enter a lysosomal glycoprotein-positive compartment, whereas 60 min were required for 90% of the spirochetes to appear in a cathepsin L-positive compartment under the same conditions. We also labeled infected living cells with acridine orange to distinguish live from killed intracellular organisms. Although the large majority of spirochetes within a given cell were dead, we saw occasional live ones up to 24 h (the longest interval examined) after all extracellular organisms had been lysed in distilled water. Moreover, we can reculture spirochetes from macrophages after infection. Persistence of spirochetes within macrophages provides a possible pathogenetic mechanism for chronic or recurrent Lyme disease in man.
Cited By (9)
- Lyme disease: A neuropsychiatric illnessAmerican Journal of Psychiatry · 1994
- LYME DISEASE:A Review of Aspects of Its Immunology and ImmunopathogenesisAnnual Review of Immunology · 1997
- Borrelia burgdorferiInduces TLR1 and TLR2 in Human Microglia and Peripheral Blood Monocytes but Differentially Regulates HLA-Class II ExpressionJournal of Neuropathology & Experimental Neurology · 2006
- Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with Lyme diseaseClinical Infectious Diseases · 2007
- Human Phagocytic Cells in the Early Innate Immune Response toBorrelia burgdorferiThe Journal of Infectious Diseases · 2002
- Persisting complaints attributed to chronic lyme disease: Possible mechanisms and implications for managementThe American Journal of Medicine · 1994
- The important and diverse roles of antibodies in the host response to Borrelia infections
Related Papers
- Herbal Therapeutics for CIRS Biomarkers in Autism Spectrum Disorders: A Mechanistic and Molecular Approach for Neuroimmune Pathology in PediatricsMedical Research Archives · 2025 · 3 shared tags
- Exploring Structured Camel Milk Therapy Alongside an Individualised Botanical Support Protocol to Facilitate Immune Modulation in a Child Diagnosed with PANS/PANDAS Co-Morbid with Lyme Disease and AutismJournal of Camel Practice and Research · 2025 · 3 shared tags
- Neuroplasticity Intervention, Amygdala and Insula Retraining (AIR), Significantly Improves Overall Health and Functioning Across Various Chronic Conditions.PubMed · 2023 · 3 shared tags
- Introduction to Chronic Inflammatory Response Syndrome (CIRS)2023 · 3 shared tags
- TUBB1, TUBA4A and MAPK as Indicators of Die-Back Degenerative Central Nervous System Disease in Patients Sickened by Specific Exposure to the Interior Environment of Water- Damaged BuildingsMedical Research Archives · 2023 · 3 shared tags
- Autism Spectrum Disorders and Lyme Disease: Exploring Shared Neuro-Inflammatory and Immune Pathways